Search Results - "Takei, Makoto"

Initiation and Up-Titration of Guideline-Based Medications in Hospitalized Acute Heart Failure Patients　― A Report From the West Tokyo Heart Failure Registry by Ohata, Takanori, Niimi, Nozomi, Shiraishi, Yasuyuki, Nakatsu, Fumiko, Umemura, Ichiro, Kohno, Takashi, Nagatomo, Yuji, Takei, Makoto, Ono, Tomohiko, Sakamoto, Munehisa, Nakano, Shintaro, Fukuda, Keiichi, Kohsaka, Shun, Yoshikawa, Tsutomu

“…Background: Despite recommendations from clinical practice guidelines to initiate and titrate guideline-directed medical therapy (GDMT) during their…”
Get full text

Potential association with malnutrition and allocation of combination medical therapies in hospitalized heart failure patients with reduced ejection fraction by Kawakubo, Yumiko, Shiraishi, Yasuyuki, Kohsaka, Shun, Kohno, Takashi, Goda, Ayumi, Nagatomo, Yuji, Nishihata, Yosuke, Saji, Mike, Takei, Makoto, Ikegami, Yukinori, Niimi, Nozomi, Sandhu, Alexander Tarlochan Singh, Nakano, Shintaro, Yoshikawa, Tsutomu, Fukuda, Keiichi

“…Malnutrition is common in patients with heart failure with reduced ejection fraction (HFrEF) and may influence the long-term prognosis and allocation of…”
Get full text

Residual high intrapulmonary shunt fraction limits exercise capacity in patients treated with balloon pulmonary angioplasty by Takei, Makoto, Kawakami, Takashi, Kataoka, Masaharu, Kuwahira, Ichiro, Fukuda, Keiichi

“…Balloon pulmonary angioplasty (BPA) has emerged as a new treatment strategy for patients with chronic thromboembolic pulmonary hypertension (CTEPH)…”
Get full text

End-of-Life Discussions and Their Timing for Patients With Cardiovascular Diseases　― From the Perspective of Bereaved Family Members by Shinada, Keitaro, Kohno, Takashi, Fukuda, Keiichi, Higashitani, Michiaki, Kawamatsu, Naoto, Kitai, Takeshi, Shibata, Tatsuhiro, Takei, Makoto, Nochioka, Kotaro, Nakazawa, Gaku, Shiomi, Hiroki, Miyashita, Mitsunori, Mizuno, Atsushi

“…Background: Enhanced discussions regarding end-of-life (EOL) are crucial to provide appropriate care for seriously ill patients. However, the current status of…”
Get full text

Divergent effect of blood glucose dysregulation on long-term clinical outcome in acute decompensated heart failure: A reappraisal in contemporary practice by Chishiki, Toshiki, Nagatomo, Yuji, Saji, Mike, Takei, Makoto, Goda, Ayumi, Kohno, Takashi, Nakano, Shintaro, Nishihata, Yosuke, Ikegami, Yukinori, Shiraishi, Yasuyuki, Kohsaka, Shun, Adachi, Takeshi, Yoshikawa, Tsutomu

“…The prognostic implication of elevated or decreased blood glucose (BG) level in acute decompensated heart failure (ADHF) has been still controversial. Indices…”
Get full text

Validation of the Get With The Guideline–Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level by Shiraishi, Yasuyuki, MD, Kohsaka, Shun, MD, PhD, Abe, Takayuki, PhD, Mizuno, Atsushi, MD, Goda, Ayumi, MD, PhD, Izumi, Yuki, MD, Yagawa, Mayuko, MD, Akita, Keitaro, MD, Sawano, Mitsuaki, MD, Inohara, Taku, MD, PhD, Takei, Makoto, MD, Kohno, Takashi, MD, PhD, Higuchi, Satoshi, MD, Yamazoe, Masahiro, MD, Mahara, Keitaro, MD, PhD, Fukuda, Keiichi, MD, PhD, Yoshikawa, Tsutomu, MD, PhD

“…Background Detailed characteristics of patients with acute heart failure (AHF) in Japan have not been elucidated. Furthermore, international application of…”
Get full text

Pharmacokinetics, distribution, and disposition of esaxerenone, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist, in rats and monkeys by Yamada, Makiko, Takei, Makoto, Suzuki, Eiko, Takakusa, Hideo, Kotsuma, Masakatsu, Washio, Takuo, Murayama, Nobuyuki, Inoue, Shin-ichi, Izumi, Takashi

“…1. Esaxerenone (CS-3150) is a novel non-steroidal mineralocorticoid receptor antagonist. The pharmacokinetics, tissue distribution, excretion, and metabolism…”
Get full text

Respiratory Function and Oxygenation after Balloon Pulmonary Angioplasty by Takei, Makoto, Kataoka, Masaharu, Kawakami, Takashi, Kuwahira, Ichiro, Fukuda, Keiichi

Get full text

Impact of Left Ventricular Chamber Size on Outcome in Heart Failure with Preserved Ejection Fraction by Ogawa, Shou, Nagatomo, Yuji, Takei, Makoto, Saji, Mike, Goda, Ayumi, Kohno, Takashi, Nakano, Shintaro, Nishihata, Yosuke, Ikegami, Yukinori, Shoji, Satoshi, Shiraishi, Yasuyuki, Kohsaka, Shun, Yoshikawa, Tsutomu

“…Although heart failure with preserved ejection fraction (HFpEF) has a highly variable phenotype, heterogeneity in left ventricular chamber size (LVCS) and its…”
Get full text

Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study by Kamiya, Kiwamu, Takei, Makoto, Nagai, Toshiyuki, Miyoshi, Toru, Ito, Hiroshi, Fukumoto, Yoshihiro, Obara, Hitoshi, Kakuma, Tatsuyuki, Sakuma, Ichiro, Daida, Hiroyuki, Iimuro, Satoshi, Shimokawa, Hiroaki, Kimura, Takeshi, Nagai, Ryozo, Anzai, Toshihisa

“…Aims: We aimed to investigate the association between non-lipid residual risk factors and cardiovascular events in patients with stable coronary artery disease…”
Get full text

Phenotyping of Elderly Patients With Heart Failure Focused on Noncardiac Conditions: A Latent Class Analysis From a Multicenter Registry of Patients Hospitalized With Heart Failure by Nakamaru, Ryo, Shiraishi, Yasuyuki, Niimi, Nozomi, Kohno, Takashi, Nagatomo, Yuji, Takei, Makoto, Ikoma, Takenori, Nishikawa, Kei, Sakamoto, Munehisa, Nakano, Shintaro, Kohsaka, Shun, Yoshikawa, Tsutomu

“…Background The burden of noncardiovascular conditions is becoming increasingly prevalent in patients with heart failure (HF). We aimed to identify novel…”
Get full text

Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials by Shoji, Satoshi, Kohsaka, Shun, Shiraishi, Yasuyuki, Kohno, Takashi, Sawano, Mitsuaki, Ikemura, Nobuhiro, Niimi, Nozomi, Nagatomo, Yuji, Tanaka, Toshikazu D., Takei, Makoto, Ono, Tomohiko, Sakamoto, Munehisa, Nakano, Shintaro, Nakamura, Iwao, Inoue, Soushin, Fukuda, Keiichi, Yoshikawa, Tsutomu

“…Recent trials on novel heart failure (HF) treatments (angiotensin receptor-neprilysin inhibitor, sodium-glucose cotransporter 2 inhibitor, and ivabradine)…”
Get full text

Effusion in transverse sinus: a primary echocardiographic sign for aortic annular rupture in transcatheter aortic valve replacement by Takei, Makoto, Hasegawa, Tasuku, Ohtsubo, Sathosi, Takahashi, Toshiyuki

Get full text

Temporal Trends in Heart Failure Management and Outcomes: Insights From a Japanese Multicenter Registry of Tertiary Care Centers by Nakamaru, Ryo, Kohsaka, Shun, Shiraishi, Yasuyuki, Kohno, Takashi, Goda, Ayumi, Nagatomo, Yuji, Kitamura, Mitsunobu, Nakano, Shintaro, Takei, Makoto, Mizuno, Atsushi, Yoshikawa, Tsutomu

“…Background The management of heart failure (HF) has markedly changed, due to changes in demographics and the emergence of novel pharmacotherapies. However,…”
Get full text

Automated radiosynthesis of [11C]MTP38—a phosphodiesterase 7 imaging tracer—using [11C]hydrogen cyanide for clinical applications by Kawamura, Kazunori, Hashimoto, Hiroki, Ohkubo, Takayuki, Hanyu, Masayuki, Ogawa, Masanao, Nengaki, Nobuki, Arashi, Daisuke, Kurihara, Yusuke, Fujishiro, Tomoya, Togashi, Takahiro, Sakai, Toshiyuki, Muto, Masatoshi, Takei, Makoto, Ishii, Hideki, Saijo, Takeaki, Matsumura, Takehiko, Obokata, Naoyuki, Zhang, Ming‐Rong

“…We have developed 8‐amino‐3‐(2S,5R‐dimethyl‐1‐piperidyl)‐[1,2,4]triazolo[4,3‐a]pyrazine‐5‐[11C]carbonitrile ([11C]MTP38) as a positron emission tomography…”
Get full text

Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction by Ito, Miyuki, Maeda, Daichi, Matsue, Yuya, Shiraishi, Yasuyuki, Dotare, Taishi, Sunayama, Tsutomu, Nogi, Kazutaka, Takei, Makoto, Ueda, Tomoya, Nogi, Maki, Ishihara, Satomi, Nakada, Yasuki, Kawakami, Rika, Kagiyama, Nobuyuki, Kitai, Takeshi, Oishi, Shogo, Akiyama, Eiichi, Suzuki, Satoshi, Yamamoto, Masayoshi, Kida, Keisuke, Okumura, Takahiro, Nagatomo, Yuji, Kohno, Takashi, Nakano, Shintaro, Kohsaka, Shun, Yoshikawa, Tsutomu, Saito, Yoshihiko, Minamino, Tohru

“…We clarified the association between changes in the number of foundational medications for heart failure (FMHF) during hospitalization for worsening heart…”
Get full text

Rationale and protocol of the LAQUA-HF trial: a factorial randomised controlled trial evaluating the effects of neurohormonal and diuretic agents on health-status reported outcomes in heart failure patients by Shiraishi, Yasuyuki, Ikemura, Nobuhiro, Urashima, Mitsuyoshi, Kohno, Takashi, Nakano, Shintaro, Tanaka, Toshikazu, Nagatomo, Yuji, Ikoma, Takenori, Ono, Tomohiko, Numasawa, Yohei, Sakamoto, Munehisa, Nishikawa, Kei, Takei, Makoto, Hakuno, Daihiko, Nakamaru, Ryo, Ueda, Ikuko, Kohsaka, Shun

“…IntroductionThe current guidelines strongly recommend early initiation of multiple classes of cardioprotective drugs for patients with heart failure with…”
Get full text

Bereaved family members' perspectives on quality of death in deceased acute cardiovascular disease patients compared with cancer patients - a comparison of the J-HOPE3 study and the quality of palliative care in heart disease (Q-PACH) study by Suzuki, Takahiro, Miyashita, Mitsunori, Kohno, Takashi, Rewley, Jeffrey, Igarashi, Naoko, Aoyama, Maho, Higashitani, Michiaki, Kawamatsu, Naoto, Kitai, Takeshi, Shibata, Tatsuhiro, Takei, Makoto, Nochioka, Kotaro, Nakazawa, Gaku, Shiomi, Hiroki, Tateno, Shigeru, Anzai, Toshihisa, Mizuno, Atsushi

“…Outcome measures during acute cardiovascular disease (CVD) phases, such as quality of death, have not been thoroughly evaluated. This is the first study that…”
Get full text

Cardiovascular vs. non‐cardiovascular deaths after heart failure hospitalization in young, older, and very old patients by Nakamaru, Ryo, Shiraishi, Yasuyuki, Sandhu, Alexander T., Heidenreich, Paul A., Shoji, Satoshi, Kohno, Takashi, Takei, Makoto, Nagatomo, Yuji, Nakano, Shintaro, Kohsaka, Shun, Yoshikawa, Tsutomu

“…Aims The long‐term outcome in patients with heart failure (HF) after hospitalization may vary substantially depending on their age and left ventricular…”
Get full text

Radiosynthesis and quality control testing of the tau imaging positron emission tomography tracer [18F]PM‐PBB3 for clinical applications by Kawamura, Kazunori, Hashimoto, Hiroki, Furutsuka, Kenji, Ohkubo, Takayuki, Fujishiro, Tomoya, Togashi, Takahiro, Arashi, Daisuke, Sakai, Toshiyuki, Muto, Masatoshi, Ogawa, Masanao, Kurihara, Yusuke, Nengaki, Nobuki, Takei, Makoto, Nemoto, Kazuyoshi, Higuchi, Makoto, Zhang, Ming‐Rong

“…Recently, we produced 11C‐labeled 2‐((1E,3E)‐4‐(6‐(methylamino)pyridin‐3‐yl)buta‐1,3‐dienyl)benzo[d]thiazol‐6‐ol ([11C]PBB3) as a clinically useful positron…”
Get full text